Ether sideways trades in relatively low volatility
Ether has been trading below its 200-day simple moving average (SMA) at $2,530.09 for the past week.
Were an advance above it to take place, the 20 June high at $2,568.97 would be eyed. If bettered, the May highs at $2,737.17-to-$2,788.12 may be reached as well ahead of Ether's early June 5-month high at $2,879.45.
Were this level to be exceeded, the 13 January low at $2,925.00 and the 27 January trough at $3,022.00 would become potential technical upside targets.
While the 200-day SMA at $2,530.09 caps on a daily chart closing basis, the 6 to 27 June lows at $2,387.06-to-$2,384.58 may be revisited.
In case of this support area giving way, the 18 May low at $2,328.10 may be probed as well.
A fall through this level would likely re-engage the April-to-July uptrend line at $2,206.63 and the 22 June low at $2,115.55.
Were this support zone to be slipped through, the March peak at $2,103.22 and 19 March high at $2,069.11 would likely be back in sight.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.